The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

Tim Schmidt

Chief Development Officer at SENISCA

Tim is SENISCA's Chief Development Officer. With 17+ years of drug development experience, Tim has previously held positions in both pharma (GSK, UCB) and biotech (TxCell, Sitryx), where he successfully led the conception and implementation of translational and early clinical development strategies, leading to the progression of several new therapeutic entities into Ph1 and 2 clinical trials.

Visit website: https://www.senisca.com/#the-team/#tim

 schmidtts

See also

SENISCA

University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing

Details last updated 13-Jan-2024

Tim Schmidt is also referenced in the following:

SENISCA

University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing